# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-092528
Filing Date
2024-04-11
Accepted
2024-04-11 08:10:59
Documents
20

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | d737147ddefa14a.htm | DEFA14A | 983382
2 | GRAPHIC | g737147dsp003.jpg | GRAPHIC | 34988
3 | GRAPHIC | g737147ex99_2s10g1.jpg | GRAPHIC | 82184
4 | GRAPHIC | g737147ex99_2s11g1.jpg | GRAPHIC | 86148
5 | GRAPHIC | g737147ex99_2s12g1.jpg | GRAPHIC | 98644
6 | GRAPHIC | g737147ex99_2s13g1.jpg | GRAPHIC | 77668
7 | GRAPHIC | g737147ex99_2s14g1.jpg | GRAPHIC | 78405
8 | GRAPHIC | g737147ex99_2s15g1.jpg | GRAPHIC | 45494
9 | GRAPHIC | g737147ex99_2s16g1.jpg | GRAPHIC | 211277
10 | GRAPHIC | g737147ex99_2s17g1.jpg | GRAPHIC | 207830
11 | GRAPHIC | g737147ex99_2s1g1.jpg | GRAPHIC | 68139
12 | GRAPHIC | g737147ex99_2s2g1.jpg | GRAPHIC | 252168
13 | GRAPHIC | g737147ex99_2s3g1.jpg | GRAPHIC | 112576
14 | GRAPHIC | g737147ex99_2s4g1.jpg | GRAPHIC | 108328
15 | GRAPHIC | g737147ex99_2s5g1.jpg | GRAPHIC | 45413
16 | GRAPHIC | g737147ex99_2s6g1.jpg | GRAPHIC | 82194
17 | GRAPHIC | g737147ex99_2s7g1.jpg | GRAPHIC | 73955
18 | GRAPHIC | g737147ex99_2s8g1.jpg | GRAPHIC | 54916
19 | GRAPHIC | g737147ex99_2s9g1.jpg | GRAPHIC | 90558
20 | GRAPHIC | g737147g0410233000495.jpg | GRAPHIC | 7572
| Complete submission text file | 0001193125-24-092528.txt |  | 3491478

Mailing Address 2801 CENTERVILLE ROAD 1ST FLOOR PMB #117 WILMINGTON DE 19808
Business Address 2801 CENTERVILLE ROAD 1ST FLOOR PMB #117 WILMINGTON DE 19808 877-354-3689
Eliem Therapeutics, Inc. (Filer) CIK: 0001768446 (see all company filings)

EIN.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40708 | Film No.: 24837174
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)